‘Mediating the Vaccine Dispute’

“AstraZeneca and the European Union (EU) are at odds over vaccine deliveries. The British-Swedish firm has encountered production problems at a European plant and wants to deliver only about 31 million doses to the EU in the first quarter instead of 80 million doses, as planned. The stakes could not be higher: the more people are vaccinated quickly against COVID-19, the fewer lives will be lost. Every day counts. However, the days pass with barren conversations, aggressive negotiation tactics, and recriminations. Last Wednesday evening, the disputing parties met in Brussels without result. The EU is owed only ‘best efforts’, says AstraZeneca, and British production is needed for the domestic market …” (more)

[Horst Eidenmüller, Oxford Business Law Blog, 1 February]

(Visited 2 times, 1 visits today)

Leave a Reply